Despite no correlation between adiponectin levels and progression of ovarian cancer (Jin et al., 2016), reduced serum adiponectin levels have been found in ovarian cancer (Jin et al., 2016; Otokozawa et al., 2015). Here, ADIPOQ is linked to ovarian carcinoma.